134 related articles for article (PubMed ID: 23624947)
1. Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AML.
Capalbo G; Mueller-Kuller T; Koschmieder S; Klein HU; Ottmann OG; Hoelzer D; Scheuring UJ
Int J Oncol; 2013 Jul; 43(1):246-54. PubMed ID: 23624947
[TBL] [Abstract][Full Text] [Related]
2. Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.
Jiang BG; Wan ZH; Huang J; Li LM; Liu H; Fu SY; Yang Y; Zhang J; Yuan SX; Wang RY; Yang Y; Gu FM; Dong LW; Pan ZY; Zhou WP
Oncotarget; 2016 Jun; 7(24):37238-37249. PubMed ID: 27191988
[TBL] [Abstract][Full Text] [Related]
3. ZC3H15 promotes glioblastoma progression through regulating EGFR stability.
Hou J; Xu M; Gu H; Pei D; Liu Y; Huang P; Chang H; Cui H
Cell Death Dis; 2022 Jan; 13(1):55. PubMed ID: 35027542
[TBL] [Abstract][Full Text] [Related]
4. ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway.
Hou J; Huang P; Lan C; Geng S; Xu M; Liu Y; Chang H; Wang Z; Gu H; Wang Y; Yang G; Cui H
Cell Death Discov; 2022 Jan; 8(1):32. PubMed ID: 35064102
[TBL] [Abstract][Full Text] [Related]
5. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
[TBL] [Abstract][Full Text] [Related]
7. 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells.
Chen PY; Wang CY; Tsao EC; Chen YT; Wu MJ; Ho CT; Yen JH
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806401
[TBL] [Abstract][Full Text] [Related]
8. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.
Wei TW; Wu PY; Wu TJ; Hou HA; Chou WC; Teng CJ; Lin CR; Chen JM; Lin TY; Su HC; Huang CF; Yu CR; Hsu SL; Tien HF; Tsai MD
Cancer Res; 2017 Jan; 77(2):494-508. PubMed ID: 28069801
[TBL] [Abstract][Full Text] [Related]
9. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
11. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
12. Human RPE expression of cell survival factors.
Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
[TBL] [Abstract][Full Text] [Related]
14. AWP1 binds to tumor necrosis factor receptor-associated factor 2 (TRAF2) and is involved in TRAF2-mediated nuclear factor-kappaB signaling.
Chang EJ; Ha J; Kang SS; Lee ZH; Kim HH
Int J Biochem Cell Biol; 2011 Nov; 43(11):1612-20. PubMed ID: 21810480
[TBL] [Abstract][Full Text] [Related]
15. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells.
Schnetzke U; Fischer M; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
Leuk Res; 2013 Nov; 37(11):1557-64. PubMed ID: 23998902
[TBL] [Abstract][Full Text] [Related]
17. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
18. HO-1 underlies resistance of AML cells to TNF-induced apoptosis.
Rushworth SA; MacEwan DJ
Blood; 2008 Apr; 111(7):3793-801. PubMed ID: 18202225
[TBL] [Abstract][Full Text] [Related]
19. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
[TBL] [Abstract][Full Text] [Related]
20. ZNF460-regulated COMMD7 Promotes Acute Myeloid Leukemia Proliferation Via the NF-κB Signaling Pathway.
Shao X; Zhong L; Chu X; Wan P; Chen S; Zhou Z; Zhang H; Wang M; Liu B
Int J Med Sci; 2023; 20(4):520-529. PubMed ID: 37057209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
